Annals of Surgical Oncology Practice Guidelines Series: Management of Primary Liver and Biliary Tract Cancers.
Samantha M RuffJordan M CloydTimothy M PawlikPublished in: Annals of surgical oncology (2023)
Primary cancers of the liver and biliary tract are rare and aggressive tumors that often present with locally advanced or metastatic disease. For patients with localized disease amenable to resection, surgery typically offers the best chance at curative-intent therapy. Unfortunately, the incidence of recurrence even after curative-intent surgery remains high. In turn, patients with hepatobiliary cancers commonly require multimodality therapy including a combination of resection, systemic therapy (i.e., targeted therapy, cytotoxic chemotherapy, immunotherapy), and/or loco-regional therapies. With advancements in the field, it is crucial for surgical oncologists to remain updated on the latest guidelines and recommendations for surgical management and optimal patient selection. Given the complex and evolving nature of treatment, this report highlights the latest practice guidelines for the surgical management of hepatobiliary cancers.
Keyphrases
- locally advanced
- minimally invasive
- clinical practice
- squamous cell carcinoma
- rectal cancer
- healthcare
- primary care
- coronary artery bypass
- small cell lung cancer
- stem cells
- coronary artery disease
- neoadjuvant chemotherapy
- radiation therapy
- quality improvement
- mesenchymal stem cells
- living cells
- atrial fibrillation
- lymph node
- open label
- phase ii study
- drug induced
- replacement therapy
- young adults
- combination therapy